These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8595091)

  • 21. Cytotoxic activity of some regioisomeric 2,3,5,10-tetrahydrobenzo[g]isoquinoline-3,5,10-triones.
    Carneiro do Nascimento S; Bouammali B; Boitard M; Pautet F; Soufiaoui M; Fillion H
    Pharmazie; 1994 Sep; 49(9):702-3. PubMed ID: 7972318
    [No Abstract]   [Full Text] [Related]  

  • 22. Novel heterocyclic family of phenyl naphthothiazole carboxamides derived from naphthalimides: synthesis, antitumor evaluation, and DNA photocleavage.
    Li Z; Yang Q; Qian X
    Bioorg Med Chem; 2005 May; 13(9):3149-55. PubMed ID: 15809150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 6- and 7-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H-dibenz[de,h] isoquinoline-1,3-diones: synthesis, nucleophilic displacements, antitumor activity, and quantitative structure-activity relationships.
    Sami SM; Dorr RT; Sòlyom AM; Alberts DS; Iyengar BS; Remers WA
    J Med Chem; 1996 Apr; 39(8):1609-18. PubMed ID: 8648600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computer assisted structure-activity correlations. Evaluation of benzo(de)isoqinoline-1,3-diones and related compounds as antitumor agents.
    Paull KD; Nasr M; Narayanan VL
    Arzneimittelforschung; 1984; 34(10):1243-6. PubMed ID: 6542782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of 5,6-dihydropyrrolo[2,1-a]isoquinolines featuring an intramolecular radical-oxidative cyclization of polysubstituted pyrroles, and evaluation of their cytotoxic activity.
    Reyes-Gutiérrez PE; Camacho JR; Ramírez-Apan MT; Osornio YM; Martínez R
    Org Biomol Chem; 2010 Oct; 8(19):4374-82. PubMed ID: 20672155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives.
    Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A
    J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antitumor activity evaluation of maleopimaric acid N-aryl imide atropisomers.
    Yao GY; Ye MY; Huang RZ; Li YJ; Zhu YT; Pan YM; Liao ZX; Wang HS
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6755-8. PubMed ID: 24211021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies about the oral bioavailability of mitonafide and 2HCl amonafide, two new cytotoxic molecules.
    Torres Suárez AI; Camacho Sánchez MA
    Farmaco; 1992 Apr; 47(4):497-508. PubMed ID: 1388597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of amonafide against primary human tumors compared with the activity of standard agents.
    Ajani JA; Baker FL; Spitzer G
    Invest New Drugs; 1988 Jun; 6(2):79-85. PubMed ID: 3170133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs.
    Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD
    J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syntheses and antitumor targeting G1 phase of the cell cycle of benzoyldihydroisoquinolines and related 1-substituted isoquinolines.
    Bermejo A; Andreu I; Suvire F; Léonce S; Caignard DH; Renard P; Pierré A; Enriz RD; Cortes D; Cabedo N
    J Med Chem; 2002 Nov; 45(23):5058-68. PubMed ID: 12408717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity.
    Van Quaquebeke E; Mahieu T; Dumont P; Dewelle J; Ribaucour F; Simon G; Sauvage S; Gaussin JF; Tuti J; El Yazidi M; Van Vynckt F; Mijatovic T; Lefranc F; Darro F; Kiss R
    J Med Chem; 2007 Aug; 50(17):4122-34. PubMed ID: 17658777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
    Bolognese A; Correale G; Manfra M; Lavecchia A; Mazzoni O; Novellino E; La Colla P; Sanna G; Loddo R
    J Med Chem; 2004 Feb; 47(4):849-58. PubMed ID: 14761187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and testing of an isoquinoline-3-carboxylic-based novel anti-tumor lead.
    Gao F; Liu H; Li L; Guo J; Wang Y; Zhao M; Peng S
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4434-6. PubMed ID: 26386603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity.
    Beggiolin G; Crippa L; Menta E; Manzotti C; Cavalletti E; Pezzoni G; Torriani D; Randisi E; Cavagnoli R; Sala F; Giuliani FC; Spinelli S
    Tumori; 2001; 87(6):407-16. PubMed ID: 11989596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of DNA strand breaks by mitonafide, an imide derivative of 3-nitro-1,8-naphthalic acid.
    Sinha BK; Strong J; Gibson NW; Kalyanaraman B
    Biochem Pharmacol; 1985 Nov; 34(21):3845-52. PubMed ID: 4062959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
    Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
    Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic and anticancer properties of some 4-aryl-3-arylcarbonyl-1-ethyl-4-piperidinols and related compounds.
    Vashishtha SC; Allen TM; Halleran S; Szydlowski J; Santos CL; De Clercq E; Balzarani J; Dimmock JR
    Pharmazie; 2001 May; 56(5):390-3. PubMed ID: 11400554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, structural characterization and in vitro cytotoxicity of diorganotin (IV) diimido complexes.
    Yin H; Yue C; Hong M; Cui J; Wu Q; Zhang X
    Eur J Med Chem; 2012 Dec; 58():533-42. PubMed ID: 23164659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of the indenone ring of indenoisoquinoline topoisomerase I inhibitors.
    Morrell A; Placzek M; Parmley S; Grella B; Antony S; Pommier Y; Cushman M
    J Med Chem; 2007 Sep; 50(18):4388-404. PubMed ID: 17676830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.